New hope for myeloma patients as platform trial tests multiple treatments
NCT ID NCT05583617
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 3 times
Summary
This study is testing several new drug combinations for people with multiple myeloma, a type of blood cancer. The trial is open to 200 participants who have already had some treatment. The goal is to see if these combinations are safe and help control the disease. Because multiple myeloma often requires ongoing treatment, this study focuses on disease control rather than a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Lyon Sud - Service Hématologie
RECRUITINGPierre-Bénite, 69310, France
-
Fundacion Jimenez Diaz
RECRUITINGMadrid, 28040, Spain
-
Hopital Bretonneau
RECRUITINGTours, 37044, France
-
Hospital Clinico Universitario de Valencia
RECRUITINGValencia, 46010, Spain
-
Hospital Universitari Germans Trias i Pujol
RECRUITINGBadalona, Barcelona, 08915, Spain
-
IGR
WITHDRAWNVillejuif, 94800, France
-
IUCT Oncopole
RECRUITINGToulouse, 31059, France
-
Oddzial Kliniczny Hematologii SPZOZ MSWiA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie
RECRUITINGOlsztyn, 10-228, Poland
-
Prince of Wales Hospital
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 03722, South Korea
-
St Vincent's Hospital Melbourne
RECRUITINGFitzroy, Victoria, 3065, Australia
-
Universitätsklinikum Hamburg-Eppendorf Onkologisches Zentrum Medizinische Klinik II
RECRUITINGHamburg, 20246, Germany
-
Universitätsklinikum Leipzig - Klinik und Poliklinik für Hämatologie
RECRUITINGLeipzig, 04103, Germany
-
Uniwersytecki Szpital Kliniczny w Poznaniu
WITHDRAWNPóźna, 60-569, Poland
-
Uniwersyteckie Centrum Kliniczne
RECRUITINGGda?sk, 80-214, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact